Clinical trial to evaluate safety and efficacy of radiofrequency ablation for malignant tumors located outside the liver - Clinical trial to evaluate safety and efficacy of radiofrequency ablation for malignant tumors located outside the liver

Division of Diagnostic Imaging and Minimally Invasive Therapy, Juntendo University Graduate School of Medicine0 sites20 target enrollmentOctober 23, 2013

Conditionsmalignant tumors which have lesions located outside the liver

Overview

Phase: Phase 3
Intervention: Not specified
Conditions: malignant tumors which have lesions located outside the liver
Sponsor: Division of Diagnostic Imaging and Minimally Invasive Therapy, Juntendo University Graduate School of Medicine
Enrollment: 20
Status: Recruiting
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

October 23, 2013

End Date

TBD

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Investigators

Sponsor

Division of Diagnostic Imaging and Minimally Invasive Therapy, Juntendo University Graduate School of Medicine

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

•1\)Tumors not visualized by ultrasonography/not accessible percutaneously 2\)Patients in whom ablation of the tumors is highly likely to cause damage of other organs or tissues 3\)Patients with marked bleeding tendency 4\)Patients with The American Society of Anesthesiologists physical state (ASA PS) 3 or more 5\)Patients who cannot follow instructions because of dementia 6\)Patients in whom therapeutic efficacy cannot be evaluated with contrast\-enhanced CT scan or others, because of renal dysfunction or adverse reactions to contrast agents 7\)Patients in whom effective measures, such as transfusion and others, cannot be used for adverse events because of religious reasons or others 8\)Patients considered to be ineligible for participation in the study by the investigator or subinvestigators